(MedPage Today) -- Nearly half (48%) of the 85 post-marketing studies ordered for the 20 drugs approved by the FDA in 2008 were pending, ongoing, or delayed as of early 2013, researchers found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment